Your body accumulates senescent cells with age. FOXO4-DRI is an investigational peptide studied for clearing them in cell and animal models.
There is a name for the cells that refuse to die. Scientists call them senescent cells. You probably call them aging.
Over time, your body accumulates cells that have stopped dividing but remain active, releasing a steady stream of inflammatory signals that disrupt surrounding tissue. This process, known as cellular senescence, is one of the proposed hallmarks of aging, and in mice, clearing senescent cells delayed age-related deterioration of several organs. How much it contributes to any individual’s fatigue, joint discomfort or slower recovery is not established.12
FOXO4-DRI is an investigational senolytic peptide. In cell and mouse studies it disrupts a survival mechanism in senescent cells so that those cells undergo programmed cell death; no controlled human trials have been published.3
At YoungerMeMD, FOXO4-DRI is part of the RestoreMe Suite, our program for patients who want to address aging at its root rather than manage symptoms after the fact.
I finally feel like my body is clearing out what it doesn’t need.
FOXO4-DRI works by disrupting the interaction between two proteins, FOXO4 and p53, that senescent cells rely on to resist programmed cell death. In laboratory and mouse studies, blocking that interaction selectively caused senescent cells to undergo apoptosis while other cells were largely spared; this selectivity has not been confirmed in people.3
What about inflammation?
Senescent cells continuously release inflammatory signals, a process called the senescence-associated secretory phenotype, or SASP. Through this secretory phenotype, senescent cells can have harmful effects on the surrounding tissue environment. Whether FOXO4-DRI lowers inflammatory markers or improves energy in people has not been studied in clinical trials.4
My recovery from workouts and day-to-day stress is noticeably better.
In mouse studies, FOXO4-DRI restored fitness, fur density and kidney function in aged mice. Whether it improves recovery, soreness or physical resilience in people has not been studied.3
What is known about blood vessels and vascular aging?
Research has shown that senescent endothelial cells, the cells that line blood vessels, are a significant contributor to vascular aging. There are no human data on cardiovascular effects of FOXO4-DRI. In a cell and mouse study, it triggered apoptosis of senescent endothelial cells and improved aortic function in aged mice.5
I wanted something that worked on aging at the cellular level, not just the surface.
FOXO4-DRI is one of a small number of compounds studied as senolytics, which target senescent cells — one of the proposed hallmarks of aging. Senolytic therapy remains experimental in people.1
FOXO4-DRI may be a strong fit if you recognize yourself in any of the following:
FOXO4-DRI is not appropriate for everyone. Our Foundational Assessment allows Dr. Varano and his provider team to review your full health picture, including lab work, symptoms, and goals, before recommending any senolytic protocol.
FOXO4-DRI is a synthetic peptide that interrupts the survival signal inside senescent cells, the aged, dysfunctional cells that accumulate in your body over time. In cell and mouse studies, disrupting this signal caused senescent cells to undergo programmed cell death and improved some measures of tissue function in aged mice. These effects have not been measured in people.3
FOXO4-DRI is administered via subcutaneous injection on a structured protocol determined by your provider. The protocol is typically short-course and intermittent, meaning it is not a daily ongoing therapy but rather a targeted reset administered at specific intervals. Your exact protocol will be built around your labs and health goals.
FOXO4-DRI has been studied in cell and mouse models, where it selectively removed senescent cells and improved some measures of tissue function, including kidney function in aged mice and testosterone production in aged male mice. No controlled human trials have been published, which is why YoungerMeMD presents this as an emerging, investigational protocol.36 Dr. Varano and his provider team will walk you through the current evidence and what it means for your specific situation.
Yes, and it often works best as part of a broader longevity protocol. FOXO4-DRI pairs well with Epitalon, which is studied for telomere support, with Thymosin Alpha-1 to address the inflammatory environment alongside senescent cell clearance, and with growth hormone peptides if you are also optimizing at the tissue regeneration level. Your provider will determine what combinations are appropriate based on your labs and goals.
Both are part of the RestoreMe Suite and both work at the level of cellular aging, but through different mechanisms. Epitalon has been studied for telomere support and for its effects on the pineal gland. FOXO4-DRI focuses on clearing cells that have already become senescent. Many patients benefit from both, and your provider may recommend using them together or in sequence depending on where you are in your health journey.
Because FOXO4-DRI works at the cellular level, the results are not always immediate or dramatic in the way a symptom-targeted therapy might feel. There are no human trial data on what to expect, so any changes patients describe are individual observations and responses vary. Repeat lab work and biomarker tracking are part of how Dr. Varano and his provider team evaluate progress and guide next steps.
Yes. All peptides used at YoungerMeMD, including FOXO4-DRI, are sourced from state-licensed compounding pharmacies that meet USP 795 and 797 standards for sterility, potency, and safety. We do not source from research-only suppliers. Your safety and the integrity of your protocol depend on the quality of what goes into your body, and we take that seriously.
FOXO4-DRI is an emerging therapy that requires the right clinical context to use safely and effectively. At YoungerMeMD, every senolytic protocol is prescribed and monitored by Dr. Varano and his provider team based on your individual labs, health history, and goals. There is no one-size-fits-all approach here.
Every FOXO4-DRI patient starts with the same three-step foundation.
$599
Your starting point. Dr. Varano and his provider team review your full health picture, including comprehensive lab work, symptom history, and longevity goals. This is how we determine whether FOXO4-DRI is the right next step for you and what your protocol should look like.
$279/month
Ongoing access to Dr. Varano and his provider team, protocol management, prescription oversight, and the ability to layer additional programs into your plan as your needs evolve.
Coming Soon
Pricing varies based on your individualized protocol length and dosing cadence. Your provider will confirm program specifics and cost following your Foundational Assessment.
Senolytic therapy works best as part of a broader longevity protocol. These programs are the most common complements Dr. Varano and his provider team recommend alongside FOXO4-DRI.
FOXO4-DRI clears the cells that have stopped working. Epitalon is studied for supporting the ones still dividing, with laboratory research on telomere length and pineal function.78 Together, they form a complementary approach to cellular aging. Many patients run these in sequence or as a combined RestoreMe protocol.
Learn about EpitalonChronic inflammation and cellular senescence are both considered interconnected hallmarks of aging. Thymosin Alpha-1 is an immune-modulating peptide; whether combining it with FOXO4-DRI improves or prolongs results has not been studied.1
Learn about Thymosin Alpha-1Sex hormones influence many tissues, and hormone levels change with age. Whether combining hormone optimization with a senolytic such as FOXO4-DRI improves results has not been studied. If hormone optimization is not already part of your protocol, it is worth discussing at your assessment.
Learn about Hormone OptimizationGrowth hormone peptides like CJC-1295 and Ipamorelin stimulate your body’s own growth hormone release. Whether reducing senescent cells changes the response to these peptides has not been studied.910
Learn about Peak PerformanceYour Foundational Assessment is where Dr. Varano and his provider team review your labs, your goals, and your full health picture to build a plan that makes sense for where you are right now.
Claim Your AssessmentFOXO4-DRI is not a shortcut. It is a targeted, physician-supervised protocol for patients who are serious about addressing cellular aging at the root. If you are ready to find out whether you are a candidate, start with the Foundational Assessment.
Fill up the form below to get started
No provocation agent required. A urine test that checks for toxic metals standard labs do not routinely test for.
Identifies gluten sensitivity, intestinal permeability (leaky gut), and wheat-related immune reactivity – distinct from standard celiac testing.
DNA Based stool test detecting pathogens, bacterial imbalances, parasites, and digestive markers – a comprehensive gut microbiome assessment.
Non-invasive carotid artery ultrasound measuring arterial wall thickness – a direct look at your cardiovascular age.
Cardio Res-Q cardiac risk panel – inflammation markers and cardiovascular biomarkers beyond standard labs.
Estimates nutrient-related markers from DNA methylation with an at-home finger-prick kit. Not a diagnostic test; flagged results are confirmed with standard blood work.
Full Sex hormone, thyroid and adrenal picture. Identifies imbalances that affect energy, recovery, cognition, and peptide response.
Advanced testing for immune reactions to wheat, gluten, and intestinal permeability.
What It Evaluates
Heavy metals like mercury, lead, cadmium, arsenic, and aluminum can cause:
Conditions We Identify
We use cookies from Google Analytics, Google Ads and Contentsquare to measure visits and ads. Nothing loads unless you click Accept. Cookie policy
